Eli Lilly (LLY) Profit After Tax Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
168.07% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.40% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.93% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-183.48% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.14% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.69% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-8.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.77% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
168.07% |
| Dec 31, 2025 |
50.52% |
| Sep 30, 2025 |
475.34% |
| Jun 30, 2025 |
90.78% |
| Mar 31, 2025 |
23.01% |
| Dec 31, 2024 |
101.43% |
| Sep 30, 2024 |
1,790.42% |
| Jun 30, 2024 |
68.27% |
| Mar 31, 2024 |
66.77% |
| Dec 31, 2023 |
12.98% |
| Sep 30, 2023 |
-103.95% |
| Jun 30, 2023 |
85.11% |
| Mar 31, 2023 |
-29.32% |
| Dec 31, 2022 |
12.26% |
| Sep 30, 2022 |
30.77% |
| Jun 30, 2022 |
-31.48% |
| Mar 31, 2022 |
40.40% |
| Dec 31, 2021 |
-18.46% |
| Sep 30, 2021 |
-8.13% |
| Jun 30, 2021 |
-1.54% |
| Mar 31, 2021 |
-6.95% |
| Dec 31, 2020 |
41.53% |
| Sep 30, 2020 |
-3.63% |
| Jun 30, 2020 |
6.39% |
| Mar 31, 2020 |
-65.66% |
| Dec 31, 2019 |
33.38% |
| Sep 30, 2019 |
14.66% |
| Jun 30, 2019 |
673.06% |
| Mar 31, 2019 |
263.40% |
| Dec 31, 2018 |
167.68% |
| Sep 30, 2018 |
96.83% |
| Jun 30, 2018 |
-122.98% |
| Mar 31, 2018 |
1,153.43% |
| Dec 31, 2017 |
-314.68% |
| Sep 30, 2017 |
-28.59% |
| Jun 30, 2017 |
34.81% |
| Mar 31, 2017 |
-125.18% |
| Dec 31, 2016 |
61.33% |
| Sep 30, 2016 |
-2.71% |
| Jun 30, 2016 |
24.45% |
| Mar 31, 2016 |
-16.88% |
| Dec 31, 2015 |
11.65% |
| Sep 30, 2015 |
59.75% |
| Jun 30, 2015 |
-18.09% |
| Mar 31, 2015 |
-27.26% |
| Dec 31, 2014 |
-41.10% |
| Sep 30, 2014 |
-58.39% |
| Jun 30, 2014 |
-39.19% |
| Mar 31, 2014 |
-52.98% |
| Dec 31, 2013 |
-12.05% |
| Sep 30, 2013 |
-9.31% |
| Jun 30, 2013 |
30.60% |
| Mar 31, 2013 |
53.10% |
| Dec 31, 2012 |
-3.61% |
| Sep 30, 2012 |
7.30% |
| Jun 30, 2012 |
-22.86% |
| Mar 31, 2012 |
-4.24% |
| Dec 31, 2011 |
-26.62% |
| Sep 30, 2011 |
-5.11% |
| Jun 30, 2011 |
-11.24% |
| Mar 31, 2011 |
-15.40% |
| Dec 31, 2010 |
27.77% |
| Sep 30, 2010 |
38.34% |
| Jun 30, 2010 |
16.44% |
| Mar 31, 2010 |
-4.95% |
